Another report indicated that METTL14 modulated the EGFR/PI3K/AKT signaling pathway to impair the migration, invasion and epithelial-mesenchymal transition (EMT) of HCC cells 24. The gene discussed is EGFR; the disease is hepatocellular carcinoma.